Last Updated: 19/06/2024
Antibody-based therapies against infectious diseases
Objectives
To develop novel antibody therapies against malaria and COVID-19.
Principal Institution
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
Principal Investigators / Focal Persons
Rationale and Abstract
Infectious diseases have resulted in devastating mortality in human populations throughout history. Antibody-based therapies have revolutionised modern medicine and will be important for the prevention and treatment of diseases caused by some of the world’s deadliest pathogens. Our program builds on a deep understanding of the molecular interactions between human and pathogen and leverages advanced antibody platforms to develop novel antibody therapies against malaria and COVID-19.
External reference
Thematic Categories
Date
Oct 2022
Total Project Funding
$1.53M
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 2016908
AUD 2.11M
Project Site
Related Resources
